MRD-response driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m(2)) in combination with lenalidomide and dexamethasone Meeting Abstract


Authors: Korde, N.; Mastey, D.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Smith, E. L.; Lendvai, N.; Hultcrantz, M.; Tavitian, E.; Salcedo, M.; Sams, A.; Diab, V.; Chung, D. J.; Scordo, M.; Lahoud, O. B.; Landau, H. J.; Arcila, M. E.; Giralt, S.; Ho, C.; Roshal, M.; Devlin, S. M.; Dogan, A.; Landgren, O.
Abstract Title: MRD-response driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m(2)) in combination with lenalidomide and dexamethasone
Meeting Title: 60th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 132
Issue: Suppl. 1
Meeting Dates: 2018 Dec 1-4
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2018-11-29
Language: English
ACCESSION: WOS:000454837605311
PROVIDER: wos
Notes: Meeting Abstract: 1983 -- Source: Wos
MSK Authors
  1. Sergio Andres Giralt
    537 Giralt
  2. Hani Hassoun
    149 Hassoun
  3. Heather Jolie Landau
    189 Landau
  4. Nikoletta Lendvai
    87 Lendvai
  5. Maria Eugenia Arcila
    350 Arcila
  6. Alexander Meyer Lesokhin
    118 Lesokhin
  7. David Chung
    83 Chung
  8. Allison Jean Sams
    2 Sams
  9. Sean McCarthy Devlin
    305 Devlin
  10. Michael Scordo
    39 Scordo
  11. Eric Smith
    36 Smith
  12. Ahmet Dogan
    174 Dogan
  13. Mikhail Roshal
    68 Roshal
  14. Carl Ola Landgren
    198 Landgren
  15. Neha Sanat Korde
    64 Korde
  16. Oscar Boutros Lahoud
    9 Lahoud
  17. Caleb   Ho
    23 Ho
  18. Donna Mastey
    4 Mastey
  19. Victoria Diab
    2 Diab